| Q4 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-03-22 | ||||||
| REV | |||||||
| Q3 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.370 | -0.310 | 0.0600 | ||||
| REV | 30.000K |
| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
You can purchase shares of Geovax Labs (NASDAQ: GOVX) through any online brokerage.
Other companies in Geovax Labs’s space includes: Panbela Therapeutics (NASDAQ:PBLA), Immuron (NASDAQ:IMRN), Brickell Biotech (NASDAQ:BBI), Midatech Pharma (NASDAQ:MTP) and BioRestorative Therapies (NASDAQ:BRTX).
The latest price target for Geovax Labs (NASDAQ: GOVX) was reported by Maxim Group on November 19, 2020. The analyst firm set a price target for 8.00 expecting GOVX to rise to within 12 months (a possible 188.81% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Geovax Labs (NASDAQ: GOVX) is $2.77 last updated Fri Jan 14 2022 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Geovax Labs.
Geovax Labs’s $Q4 earnings are confirmed for after-market on March 22, 2022.
There is no upcoming split for Geovax Labs.
Geovax Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.